Enjoy complimentary customisation on priority with our Enterprise License!
The cancer gene therapy market size has the potential to grow by USD 2.96 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 20.13%.
This report provides a detailed analysis of the market by therapy (oncolytic virotherapy, gene transfer, and gene-induced immunotherapy), geography (North America, Europe, Asia, and ROW), and key vendors.
Browse TOC and LoE with selected illustrations and example pages of Cancer Gene Therapy Market
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
The cancer gene therapy market is fragmented and the vendors are deploying growth strategies such as R&D to compete in the market. Click here to uncover other successful business strategies deployed by the vendors.
The market players also significantly leverage external market drivers such as the side effects of traditional cancer treatments to achieve growth opportunities. However, factors such as the high cost of gene therapy treatment will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Download a free sample of the cancer gene therapy market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
This cancer gene therapy market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of their future growth opportunities.
|
|
Grab your Free Sample now to unlock further information on other key market drivers
For more insights on the market share of various regions Request for a FREE sample now!
51% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for cancer gene therapy in North America. Market growth in this region will be slower than the growth of the market in Asia and ROW.
The huge investment in the R&D activities for the healthcare segment to curb the rising number of cancer-related deaths is one of the prime factors that will facilitate the cancer gene therapy market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.
Request for a FREE sample and Get more information on the market contribution of various segments
The oncolytic virotherapy is the primarily preferred treatment. This therapy involved the use of anticancer cells that destroy the cancer cells without harming the normal cells. Residual tumor cells are killed by anti-tumor immune response through this therapy. Hence the market segment will exhibit a fast growth rate during the forecast period.
Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the cancer gene therapy market size.
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Therapy
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
